Benefits and limits of hepatic resection for gastric metastases.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 11376587)

Published in Am J Surg on March 01, 2001

Authors

S Ambiru1, M Miyazaki, H Ito, K Nakagawa, H Shimizu, H Yoshidome, Y Shimizu, N Nakajima

Author Affiliations

1: First Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba, Japan.

Articles citing this

Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg (2005) 1.41

Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg (2012) 1.28

Strategies for treating liver metastasis from gastric cancer. Surg Today (2010) 1.02

Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg (2008) 1.02

Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer (2014) 1.01

Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (Oxford) (2012) 1.01

Liver resections in metastatic gastric cancer. HPB (Oxford) (2010) 1.00

The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg (2014) 1.00

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int (2010) 0.99

Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis. World J Surg (2012) 0.97

Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature. HPB (Oxford) (2006) 0.96

Long-term survival after resection of metachronous bilateral adrenal metastases of mucinous gastric carcinoma: report of a case. Surg Today (2006) 0.89

Surgical treatment of recurrent gastric cancer. Gastric Cancer (2008) 0.89

Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer (2011) 0.89

Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg (2012) 0.87

Surgical treatment of liver metastases of gastric cancer: state of the art. World J Surg Oncol (2012) 0.85

Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma. Yonsei Med J (2008) 0.85

Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma. World J Surg (2013) 0.85

Surgery for liver metastasis from gastric cancer. Transl Gastroenterol Hepatol (2016) 0.83

Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.83

Hepatic resection for hepatic metastases from gastric adenocarcinoma. J Gastric Cancer (2013) 0.81

Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer (2015) 0.81

Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing. Med Sci Monit (2011) 0.81

Hepatic metastases from gastric cancer: A surgical perspective. World J Gastroenterol (2015) 0.80

A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1. Int J Clin Oncol (2007) 0.80

Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol (2008) 0.80

Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports. Cancer Res Treat (2006) 0.79

A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival. Langenbecks Arch Surg (2008) 0.79

Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study. World J Surg Oncol (2015) 0.78

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastasis (2013) 0.78

Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer (2016) 0.77

High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg (2014) 0.76

Long-term survival with complete remission after hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer: a case report. World J Surg Oncol (2015) 0.75

Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. Chin Med J (Engl) (2015) 0.75

Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol (2017) 0.75

Clinical modalities for management of gastric cancer hepatic metastasis. Int J Clin Exp Med (2015) 0.75

Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer. World J Gastroenterol (2015) 0.75

Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surg (2017) 0.75

Long-term recurrence-free survival after metachronous surgery of the stomach and liver for gastric adenocarcinoma and multiple, synchronous liver metastases: a case report and review of literature. Int Surg (2013) 0.75

Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤3 Metastatic Tumors with Diameters <3 cm from Gastric Cancer: A Retrospective Study. World J Surg (2015) 0.75

Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis. Oncotarget (2017) 0.75

Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study. PLoS One (2017) 0.75

Articles by these authors

Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91

Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90

Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 8.64

THE ETIOLOGY, MODE OF INFECTION, AND SPECIFIC THERAPY OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 8.21

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med (2000) 6.68

PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol (1996) 6.68

Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res (1996) 6.62

Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support. Nucleic Acids Res (1982) 6.38

A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1995) 6.00

Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ (2004) 5.49

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36

Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med (1990) 4.88

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82

Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38

PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis (2004) 4.33

THE PROPHYLAXIS OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 4.33

Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24

Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15

The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol (1990) 4.03

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99

THE RAT AS A CARRIER OF SPIROCHAETA ICTEROHAEMORRHAGIAE, THE CAUSATIVE AGENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1917) 3.80

Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol (1999) 3.75

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature (1985) 3.59

THE SERUM TREATMENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA). J Exp Med (1916) 3.24

Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol (2006) 3.12

Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene (1994) 3.08

IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08

Studies on the mass receptor potential of the isolated frog retina. II. On the basis of the ionic mechanism. Vision Res (1969) 2.91

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer (2010) 2.82

Polypeptide chain elongation factor 1 alpha (EF-1 alpha) from yeast: nucleotide sequence of one of the two genes for EF-1 alpha from Saccharomyces cerevisiae. EMBO J (1984) 2.77

Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. J Immunol (1983) 2.72

Effects of the complete removal of basic amino acid residues from the signal peptide on secretion of lipoprotein in Escherichia coli. J Biol Chem (1983) 2.66

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66

A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev (2001) 2.59

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54

Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48

Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol Cell Biol (1993) 2.48

Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol (1995) 2.47

Organization and structure of an E. coli tRNA operon containing seven tRNA genes. Cell (1981) 2.45

CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med (1992) 2.38

Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology (2000) 2.37

Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet (1994) 2.36

Chlorophyll a oxygenase (CAO) is involved in chlorophyll b formation from chlorophyll a. Proc Natl Acad Sci U S A (1998) 2.35

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33

NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis (2001) 2.30

Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res (1994) 2.29

Coupling of the TCR to integrin activation by Slap-130/Fyb. Science (2001) 2.26

A large family of class III plant peroxidases. Plant Cell Physiol (2001) 2.21

Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21

Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines. Proc Natl Acad Sci U S A (1970) 2.19

Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes. EMBO J (1997) 2.19

A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol (2000) 2.16

Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis (1999) 2.16

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16

Studies on the nucleotide sequence of pseudouridine-containing 5S RNA from Saccharomyces cerevisiae. J Biochem (1974) 2.15

Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem (2001) 2.14

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel. Ann Oncol (2009) 2.14

A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain. J Neurochem (1969) 2.13

Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol (1994) 2.11

Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11

p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. Eur J Neurol (2013) 2.11

LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science (1990) 2.09

Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09

Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun (1996) 2.09

Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy (2004) 2.08

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut (2008) 2.05

Dhh1p, a putative RNA helicase, associates with the general transcription factors Pop2p and Ccr4p from Saccharomyces cerevisiae. Genetics (1998) 2.02

Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med (1991) 2.02

Keratosis follicularis squamosa (Dohi): a follicular keratotic disorder well known in Japan. Br J Dermatol (2001) 2.01

Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (1996) 2.00

Formation of the male-specific muscle in female Drosophila by ectopic fruitless expression. Nat Cell Biol (2000) 1.99

Studies on the mass receptor potential of the isolated frog retina. I. General properties of the response. Vision Res (1969) 1.97

Successful nonsurgical management of perforation complicating endoscopic submucosal dissection of gastrointestinal epithelial neoplasms. Endoscopy (2006) 1.97

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med (1999) 1.95

Eccrine porocarcinoma and Bowen's disease arising in a seborrhoeic keratosis. Clin Exp Dermatol (2006) 1.95

Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol (1993) 1.94

Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res (2001) 1.91

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer (2006) 1.91

Monte Carlo dosimetry of 60Co HDR brachytherapy sources. Med Phys (2003) 1.90

Demonstration of mother-to-infant transmission of hepatitis B virus by means of polymerase chain reaction. Lancet (1989) 1.90

Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology (1998) 1.90

New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol (1988) 1.85

Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob Agents Chemother (1997) 1.84

Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1999) 1.82

[Red free light magnifying photography in neuritis and some retinal vascular lesions]. Nihon Ganka Kiyo (1969) 1.81

Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care (1999) 1.78

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Aliment Pharmacol Ther (2001) 1.77

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77

Reliability and validity of a questionnaire for assessment of energy expenditure and physical activity in epidemiological studies. J Epidemiol (1998) 1.76

Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75